These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31252286)

  • 41. Arylazolyl(azinyl)thioacetanilides. Part 16: Structure-based bioisosterism design, synthesis and biological evaluation of novel pyrimidinylthioacetanilides as potent HIV-1 inhibitors.
    Li X; Lu X; Chen W; Liu H; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2014 Oct; 22(19):5290-7. PubMed ID: 25150090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocket.
    Stewart KD; Huth JR; Ng TI; McDaniel K; Hutchinson RN; Stoll VS; Mendoza RR; Matayoshi ED; Carrick R; Mo H; Severin J; Walter K; Richardson PL; Barrett LW; Meadows R; Anderson S; Kohlbrenner W; Maring C; Kempf DJ; Molla A; Olejniczak ET
    Bioorg Med Chem Lett; 2010 Jan; 20(2):612-7. PubMed ID: 20004576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel preventive strategy against HIV-1 infection: combinatorial use of inhibitors targeting the nucleocapsid and fusion proteins.
    Yang Y; Zhu J; Hassink M; Jenkins LMM; Wan Y; Appella DH; Xu J; Appella E; Zhang X
    Emerg Microbes Infect; 2017 Jun; 6(6):e40. PubMed ID: 28588284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationally Designed Peptides as Efficient Inhibitors of Nucleic Acid Chaperone Activity of HIV-1 Nucleocapsid Protein.
    Shvadchak V; Zgheib S; Basta B; Humbert N; Langedijk J; Morris MC; Ciaco S; Maskri O; Darlix JL; Mauffret O; Fossé P; Réal E; Mély Y
    Biochemistry; 2018 Jul; 57(30):4562-4573. PubMed ID: 30019894
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hit optimization studies of 3-hydroxy-indolin-2-one analogs as potential anti-HIV-1 agents.
    Chander S; Tang CR; Penta A; Wang P; Bhagwat DP; Vanthuyne N; Albalat M; Patel P; Sankpal S; Zheng YT; Sankaranarayanan M
    Bioorg Chem; 2018 Sep; 79():212-222. PubMed ID: 29775947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reaction Kinetics Direct a Rational Synthesis of an HIV-1 Inactivator of Nucleocapsid Protein 7 and Provide Mechanistic Insight into Cellular Metabolism and Antiviral Activity.
    Nikolayevskiy H; Scerba MT; Deschamps JR; Appella DH
    Chemistry; 2018 Jul; 24(38):9485-9489. PubMed ID: 29653024
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study.
    Leonis G; Steinbrecher T; Papadopoulos MG
    J Chem Inf Model; 2013 Aug; 53(8):2141-53. PubMed ID: 23834142
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Syntheses and anti-HIV activities of (+/-)-norcarbovir and (+/-)-norabacavir.
    Huang W; Miller MJ; De Clercq E; Balzarini J
    Org Biomol Chem; 2007 Apr; 5(8):1164-6. PubMed ID: 17406712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. C-3 benzoic acid derivatives of C-3 deoxybetulinic acid and deoxybetulin as HIV-1 maturation inhibitors.
    Liu Z; Swidorski JJ; Nowicka-Sans B; Terry B; Protack T; Lin Z; Samanta H; Zhang S; Li Z; Parker DD; Rahematpura S; Jenkins S; Beno BR; Krystal M; Meanwell NA; Dicker IB; Regueiro-Ren A
    Bioorg Med Chem; 2016 Apr; 24(8):1757-70. PubMed ID: 26968652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toward Structurally Novel and Metabolically Stable HIV-1 Capsid-Targeting Small Molecules.
    Vernekar SKV; Sahani RL; Casey MC; Kankanala J; Wang L; Kirby KA; Du H; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32316297
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical evaluation of a zinc finger inhibitor targeting lentivirus nucleocapsid protein in SIV-infected monkeys.
    Schito ML; Soloff AC; Slovitz D; Trichel A; Inman JK; Appella E; Turpin JA; Barratt-Boyes SM
    Curr HIV Res; 2006 Jul; 4(3):379-86. PubMed ID: 16842089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and evaluation of 2-pyridinylpyrimidines as inhibitors of HIV-1 structural protein assembly.
    Kožíšek M; Štěpánek O; Parkan K; Berenguer Albiñana C; Pávová M; Weber J; Krӓusslich HG; Konvalinka J; Machara A
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3487-90. PubMed ID: 27353536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis, biophysical characterization and anti-HIV activity of d(TG3AG) Quadruplexes bearing hydrophobic tails at the 5'-end.
    Romanucci V; Milardi D; Campagna T; Gaglione M; Messere A; D'Urso A; Crisafi E; La Rosa C; Zarrelli A; Balzarini J; Di Fabio G
    Bioorg Med Chem; 2014 Feb; 22(3):960-6. PubMed ID: 24433967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-HIV activity of N-1-adamantyl-4-aminophthalimide.
    Van Derpoorten K; Balzarini J; De Clercq E; Poupaert JH
    Biomed Pharmacother; 1997; 51(10):464-8. PubMed ID: 9863507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A survey of core replacements in indole-based HIV-1 attachment inhibitors.
    Wang T; Wallace OB; Zhang Z; Fang H; Yang Z; Robinson BA; Spicer TP; Gong YF; Blair WS; Shi PY; Lin PF; Deshpande M; Meanwell NA; Kadow JF
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1423-1429. PubMed ID: 30940396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of the biotinylated anti-HIV compound BMMP and the target identification study.
    Kamo M; Tateishi H; Koga R; Okamoto Y; Otsuka M; Fujita M
    Bioorg Med Chem Lett; 2016 Jan; 26(1):43-5. PubMed ID: 26615887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents.
    Liu X; Chen P; Li X; Ba M; Jiao X; Guo Y; Xie P
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1699-1703. PubMed ID: 29699924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis, Molecular Modelling and Biological Studies of 3-hydroxypyrane- 4-one and 3-hydroxy-pyridine-4-one Derivatives as HIV-1 Integrase Inhibitors.
    Sirous H; Fassihi A; Brogi S; Campiani G; Christ F; Debyser Z; Gemma S; Butini S; Chemi G; Grillo A; Zabihollahi R; Aghasadeghi MR; Saghaie L; Memarian HR
    Med Chem; 2019; 15(7):755-770. PubMed ID: 30569867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses.
    Schinazi RF; Hernandez-Santiago BI; Hurwitz SJ
    Antiviral Res; 2006 Sep; 71(2-3):322-34. PubMed ID: 16716415
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of the HIV NCp7 Protein with Platinum(II) and Gold(III) Complexes Containing Tridentate Ligands.
    Bernardes VH; Qu Y; Du Z; Beaton J; Vargas MD; Farrell NP
    Inorg Chem; 2016 Nov; 55(21):11396-11407. PubMed ID: 27934299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.